In a paper published in the journal Science Advances, scientists led by Eric Shusta from the University of Wisconsin-Madison, US, detail how molecules extracted from sea lampreys (Petromyzon marinus) – a common northern hemisphere jawless species – could be used to ferry medications to targets within the brain.